Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer

Table 1

Demography and clinicopathological profile of study participants.

Characteristics (n=39)		Number, %
Age, years	<=35	04 (10.2%)
	36-50	23 (58.9%)
	>51	12 (30.7%)
Tumor Location	Upper Inner Quadrant	05 (15.4%)
	Upper Pole	Nil
	Upper Outer Quadrant	22 (56.4%)
	Central	02 (5.1%)
	Lower Outer Quadrant	06 (15.4%)
	Lower Pole	01 (2.5%)
	Lower Inner Quadrant	06 (15.4%)
	Others	01(2.6%)
Type of Tumor	DCIS	02 (5.1%)
	IDC	26 (66.7%)
	IDC + DCIS	07(17.9%)
	Others	4 (10.3%)
Receptor Status	ER Positive	26 (66.7%)
	PR Positive	20 (51.3%)
	Her-2 Positive	13 (33.3%)
	TNBC	06 (15.14%)
Grade	I	1 (2.6%)
	II	26 (66.7%)
	III	08 (20.5%)
Stage	0	1 (2.6%)
	I	3 (7.7%)
	II	18(46.1%)
	III	12(30.7%)
NACT	-	17(43.6%)
Adjuvant Chemotherapy	-	28 (71.8%)
RT	-	32 (82.05%)

Data for all 39 patients could not be obtained due to being lost to follow-up.